Bearish flow noted in Teva with 7,315 puts trading, or 4x expected. Most active are Oct-24 16 puts and 10/4 weekly 17.5 puts, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 2.43, while ATM IV is up over 2 points on the day. Earnings are expected on November 6th.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Teva launches generic version of Sandostatin LAR Depot in the U.S.
- Teva announces new analysis from European cohort of RIM-TD study
- Teva presents new Phase 3 efficacy, safety data from SOLARIS trial
- EU set to fine Teva for disparaging rival to Copaxone, Reuters reports
- Teva case for multiple expansion ‘remains solid,’ says Jefferies